Biotech

All Articles

Pfizer takes $230M struck after axing stopped working DMD gene therapy

.Pfizer's period 3 Duchenne muscle dystrophy (DMD) gene treatment failing has actually blown a $230 ...

AC Immune finds 'site' prospective in Alzheimer's medication records

.After greater than 20 years of work on neurodegenerative illness, Swiss biotech hvac Invulnerable i...

GSK loses ph. 2 HPV vaccination over shortage of best-in-class potential

.GSK has actually scrapped a phase 2 individual papillomavirus (HPV) vaccine coming from its own pip...

OS Therapies refiles $6M IPO to cash HER2 medicine, preclinical ADCs

.Operating system Therapies are going to detail on the NYSE American sell exchange this morning by m...

ALX's fizzling CD47 action rate delivers inventory spiraling down

.ALX Oncology's stage 2 gastric cancer cells action price has damaged. After observing its CD47 bloc...

Ionis centers eye health condition coming from aim ats of Roche-partnered possibility after records let down

.One More of Ionis Pharmaceuticals' vital midphase readouts has actually disappointed assumptions, p...

Biogen's CEO stated no dangerous sell 2023. He prepares to be bold

.While Biogen's pharma peers are looking for late-stage possessions with little danger, CEO Chris Vi...

Instil refills pipeline in $2B biobucks manage ImmunOnco

.Instil Biography has actually been actually a biotech looking for a pipe after it ditched its lead ...

Biogen ignores Denali Alzheimer's collab

.Biogen has actually handed back legal rights to a very early Alzheimer's illness system to Denali T...

Takeda faucets brand new head of US oncology business-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of notable management hirings, firings and r...